FDA PCAC reviews 7 peptides for the 503A bulks list (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, Epitalon). Read our compounder's decision tree. Read our briefing →
FDA PCAC reviews 7 peptides for the 503A bulks list in July. Read →
FDA PCAC: 7 peptides under review. Read →
Porcine-brain-derived neurotrophic peptide complex
Overview
Cerebrolysin is a complex mixture of low-molecular-weight peptides and free amino acids obtained from standardised enzymatic hydrolysis of purified porcine brain tissue. It contains a broad spectrum of neurotrophic and neuroprotective peptide fractions and is studied in neurodegeneration, stroke-recovery, and cognitive research models for reported neurotrophic-factor-like activity. Because it is a defined mixture rather than a single molecule, the released-batch COA characterises it by total peptide content (≥95.0%), peptide-profile mapping by LC-MS, molecular-weight distribution (<10 kDa majority), water, endotoxin, heavy metals, residual solvents, and microbial limits, rather than by a single HPLC main-peak.
Applications & buyer fit
Cognitive and neuropeptide buyers are predominantly research labs running in vivo rodent studies. The dominant administration route in the literature is intranasal, these peptides are not meaningfully blood-brain-barrier permeable when delivered systemically. For in vivo workflows, endotoxin and microbial-limit testing is recommended at the COA stage so the bioassay readout is not confounded by contamination unrelated to the test article.
Sourced for
Buyer fit
Documentation that ships
Procurement note: For in vivo workflows, endotoxin and microbial-limit testing on the specific lot is recommended at the COA stage.
Primary buyer fit: academic and contract research laboratories.
Specifications
Certificate of Analysis
Published released-batch COAs for Cerebrolysin (Peptide Complex), every lot HPLC-verified. These are previews — request the full high-resolution certificate for any lot.
Browse all published COAsRegulatory note
Porcine-derived peptide complex marketed as a finished medicine in some jurisdictions; supplied by Vialdyne strictly as a research-use-only reference material, not for human or veterinary use. Buyers must verify import and regulatory status in the destination market.
Frequently asked questions
Cerebrolysin is not one molecule, it is a standardised peptide complex produced by enzymatic hydrolysis of porcine brain tissue, containing many low-molecular-weight peptides and amino acids. Because of that, it is characterised by total peptide content, peptide-profile mapping, and molecular-weight distribution rather than by a single CAS number or formula. The released-batch COA documents this mixture-level fingerprint so lot-to-lot consistency can be verified.
Each lot is released against a ≥95.0% total-peptide-content specification with LC-MS peptide-profile mapping, a <10 kDa majority molecular-weight distribution, plus water, endotoxin, heavy metals, residual solvents, and microbial-limit testing. It is supplied lyophilised and held at 2–8°C protected from light. Vialdyne provides it as a research reference material only and makes no therapeutic claim.
Related peptides
